https://www.avient.com/sites/default/files/2021-06/fl.a4.datasheet-novoloid.pdf
Abrasion Resistance Ultraviolet (UV) Resistance Flame Resistance Chemical Resistance (Acid Chemical Resistance (Alkali) Chemical Resistance (Organic Solvent) Strength Retention (H2O) O P P P P P P Property UOM Value Breaking Tenacity g/d 1.5 Specific Gravity Ratio 1.27 Elongation @ Break % 30.0 - 40.0 Tensile Modulus g/d 2.5 - 5.0 Moisture Regain* % 6.0 Creep** % N/A Shrinkage*** % < 0.1 Melt Point °C N/A Decomposition Temp.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
D is t. ) R P M K W R P P G F U L A V Y G C P F M C IF F H X L H U N F O E E M N E C L S C L K R A A S H C E G R A A L B Median: 5%Median: 3% Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Source: Bloomberg market data as of November 9, 2020 Median: 82% Median: 73% HIGH FREE CASH FLOW CONVERSION 83 86 85 85 80 78 58 88 83 81 79 77 76 73 73 72 72 67 64 63 60 6 A v ie n t K W R R P M P P G F U L A V Y G C P F M C IF F U N V R B N R E M N E C L C E H X L F O E A S H G R A H U N K R A S C L A L B Net Debt / 2021E EBITDA (1) We typically operate at 2.5–3.0x net debt to EBITDA.
Using consensus EBITDA of $466M per Bloomberg Source: Bloomberg market data as of November 9, 2020 OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.7 18.1 14.0 14.0 13.6 11.7 10.2 23.8 18.7 17.7 13.7 12.2 11.4 11.4 11.4 11.0 10.4 9.5 9.2 8.4 8.3 7.6 A v ie n t K W R R P M P P G A V Y G C P F U L E C L A L B H X L IF F F M C C E F O E A S H B N R G R A S C L E M N U N V R H U N K R A Median: 11.4xMedian: 13.8x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2023-08/Hydrocerol Chemical Foaming Agents - PP Door Panel - Application Snapshot 2.pdf
AUTOMOTIVE OEM P P D O O R P A N E L • Reduce weight while maintaining exact mechanical properties • Provide a more sustainable solution • Reduce CO2 emissions in material production and in the use phase • Offered formulation expertise and a broad portfolio of solutions • Provided technical support to help with product selection and processing parameters • Achieved good surface finish • Enabled a 20% weight reduction Hydrocerol™ Chemical Foaming Agents KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2022-03/Trilliant HC Conductive Pipette Tips Application Snapshot.pdf
LEADING BIOTECH MANUFACTURER C O N D U C T I V E P I P E T T E T I P S • Accuracy of liquid measurements • Hydrophobic properties to minimize fluid retention • Concentric dimensional stability and warp resistance • High flow properties for multi-cavity molds • Offered consistent electrical conductivity to achieve repeatable part performance and minimize failures from inconsistent conductivity • Provided high flow grade with easy processing to improve efficiency and cost effectiveness • Achieved high stiffness and warp resistance, minimizing the rejection rate Trilliant™ HC Conductive Formulation KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2022-01/Dynaflex-Disposable syringe tip cap-Application snapshot.pdf
SYRINGE MANUFACTURING D I S P O S A B L E S Y R I N G E T I P C A P • Excellent sealing and resealing performance • No DEHP or natural rubber latex added during processing • Can be sterilized by EtO • Compliance with ISO 10993-4&5, USP Class VI Dynaflex™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-01/Core Radiation Protection Case Study Snapshot.pdf
RADIATION PROTECTION OEM P E R S O N A L P R O T E C T I O N A P R O N S • Enhanced performance and compatibility with other materials being used during production • Improved durability in various environments • Onsite technical and processing support • Formulations in clear, neutral and black shades • Formulated a plastisol solution for better dispersion of customer’s raw materials and enhanced compatibility with pigments being used • Provided superior indoor and outdoor performance for the end application • Offered onsite support to help streamline processing • Delivered a range of colors to meet brand requirements CORE™ Vinyl Plastisols KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2024-12/Oncolor Lux Colorants - PP Cap - case study snapshot.pdf
INHALER ROLL BRAND P P I N H A L E R R O L L C A P • Provide green glow-in-the-dark effect colorants • Offer good glowing performance but with a low dosage • Meet a short delivery lead-time and cost-effective solution • Met customer’s glowing effect requirement of more than 8 hours with a 2% dosage • Offered strong product innovation ability to support customer’s product differentiation with special effects • Provided a short lead time and cost- effectiveness with local production OnColor Lux Colorants KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-earnings-presentation_0.pdf
D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of October 25, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $580M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of October 25, 2021 86 92 85 82 79 77 74 89 83 82 80 79 79 78 78 72 33 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E H X L B N R A S H E C L E M N H U N S C L A L B (12) Source: Peer data per Bloomberg market data as of October 25, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the median of other selected chemical / specialty companies.
With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.0 18.3 16.3 15.4 14.5 11.6 11.1 36.2 28.0 24.9 13.0 11.5 11.3 10.0 9.2 8.8 7.7 6.7 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2020-05/2.-polyone-ir-presenstation-wells-fargo-industrials-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P LE P RO D U CT S P LA N E T P E RF O R MAN C E •• •• •• JVs Performance Products & Solutions Distribution Specialty To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax(1) Special items, tax adjustments(1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S).
https://www.avient.com/sites/default/files/2020-05/1.-polyone-ir-presenstation-fermium-research-chemicals-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8 • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • P E O P LE P RO D U CT S P LA N E T P E RF O R MAN C E •• •• •• JVs Performance Products & Solutions Distribution Specialty To be the world’s premier provider of specialized polymer materials, services and solutions To be the world’s premier provider of specialized polymer materials, services and sustainable solutions • • • • • • • • • • • • • • 2016 2017 2018 2019 Lightweighting Reduced Material Requirements Improved Recyclability Renewable Energy Applications Eco-conscious Bio-derived Content Reduced Energy Use VOC Reduction $275M $325M $355M $410M 14% Total Annual Growth 9% Organic Annual Growth PolyOne Corporation 33 Adjusted EPS attributable to PolyOne common shareholders is calculated as follows: 2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018*** Q1 2019*** 2019 Q1 2020 Net income from continuing operations attributable to PolyOne common shareholders Joint venture equity earnings, after tax Special items, before tax(1) Special items, tax adjustments(1) Adjusted net income from continuing operations attributable to PolyOne common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1 (19.0) (14.7) (3.7) — — — — — — — — — — — (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6 (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0) $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7 Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation. ** Pro forma for sale of Designed Structures and Solutions segment (DSS). *** Pro forma for sale of Performance Products and Solutions segment (PP&S).